Overview

ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia

Status:
Unknown status
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
To assess whether ATG Combined With Cyclophosphamide and cord blood infusion can accelerate hematopoietic reconstruction in severe aplastic anemia patients and improve clinical curative effect and safety
Phase:
Phase 4
Details
Lead Sponsor:
Jinan Military General Hospital
Collaborators:
Affiliated Hospital of Weifang Medical University
Cancer Hospital of Henan Province
Guangzhou First People's Hospital
Harbin Hematology and Oncology Institute
Institute of Hematology & Blood Diseases Hospital
JIANGXI Provincal People's Hospital
Jinhua Central Hospital
Jining Medical University
Jining No.1 People`s Hospital
Liaocheng People's Hospital
Linyi People's Hospital
Qingdao Hiser Medical Group
Qingdao University
Shandong Cord Blood Bank
Shandong Jining No.1 People's Hospital
Shandong University of Traditional Chinese Medicine
Shengjing Hospital
Taian City Central Hospital
The First Affiliated Hospital of Xiamen University
Weifang Medical University
Yantai Yuhuangding Hospital
Yishui Central Hospital of LINYI
Zhangzhou Municipal Hospital of Fujian Province
Zhongshan Hospital Xiamen University
Treatments:
Cyclophosphamide
Cyclosporine
Cyclosporins
Immunosuppressive Agents
Thymoglobulin